SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-058818
Filing Date
2024-05-13
Accepted
2024-05-13 17:05:44
Documents
72
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tsbx-20240331.htm   iXBRL 10-Q 2360099
2 EX-10.1 tsbx-ex10_1.htm EX-10.1 355225
3 EX-31.1 tsbx-ex31_1.htm EX-31.1 13045
4 EX-31.2 tsbx-ex31_2.htm EX-31.2 13241
5 EX-32.1 tsbx-ex32_1.htm EX-32.1 8330
6 GRAPHIC img127451225_0.jpg GRAPHIC 80685
  Complete submission text file 0000950170-24-058818.txt   10027240

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tsbx-20240331.xsd EX-101.SCH 1464560
76 EXTRACTED XBRL INSTANCE DOCUMENT tsbx-20240331_htm.xml XML 1550893
Mailing Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037
Business Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

IRS No.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41747 | Film No.: 24940186
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)